Overview / Abstract: |
In two virtual roundtables, a pulmonologist, infectious disease specialist, and clinical pharmacist share their experiences in addressing challenges in diagnosing and treating patients with NTM-LD. The expert panel discusses strategies for expediting diagnosis and improving patient care and outcomes within the context of a patient’s reflections on the path to diagnosis and their treatment experience. Through this approach, learners hear from a real-world patient as the multidisciplinary panel examines the timeline to diagnosis and approach to optimal management. |
Expiration |
Feb 28, 2023 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME |
Format |
Online, Webinar / Webcast / Video |
Credits / Hours |
1.50 AMA PRA Category 1 Credit(s). 1.50 Contact Hours |
Accreditation |
ACCME, ACPE |
Presenters / Authors / Faculty |
Christina O’Connor, PharmD, BCPS, AAHIV-P Stephen Ruoss, MD Jason Stout, MD, MHS |
Activity Specialities / Related Topics |
Family Medicine, Infectious Disease, Internal Medicine, Pharmacology, Primary Care, Pulmonary Medicine / COPD |
Sponsors / Supporters / Grant Providers |
Supported by an educational grant from Insmed Incorporated. |
Keywords / Search Terms |
ACHL Ruoss, Stout, Multidisciplinary, roundtable, diagnosis, epidemiology, pathogenicity, azithromycin, rifampicin, ethambutol, amikacin, streptomycin, isoniazid, imipenem, cefoxitin, tigecycline, clofazimine, linezolid, moxifloxacin NTM-LD, nontuberculous, mycobacterial, lung disease; rifabutin, clarithromycin, Mycobacterium avium complex, MAC Free CE CME |